Trends

UK’s referendum — its implication on the Unitary Patent System

UK’s referendum — its implication on the Unitary Patent System

UK’s referendum — its implication on the Unitary Patent System

24.06.2016

Yesterday, on 23rd June 2016, the United Kingdom has decided, through a public referendum, to leave the European Union.  Aside from the many other consequences of this vote, the decision also has a direct impact on the Unitary Patent/Unified Patent Court system because this new system is not open for participation of a non-EU member state.

As a reminder, the Unitary Patent “package”, whose purpose is to set up a European Patent with a unitary effect on the territories of the 26 participating member states, will come into effect when 13 countries, including France, UK, and Germany have ratified the Unified Patent Court (UPC) agreement. Bulgaria, which was the 10th and latest country to ratify it, did so on 3rd June 2016, meaning only 3 member states (including UK and Germany) have still to ratify.

In accordance with the Treaty on the European Union, a withdrawal agreement must now be concluded between the UK and the EU, and the Treaties will cease to apply to the UK from the date of entry into force of this withdrawal agreement or, failing that, two years after the UK has issued its withdrawal notification (unless otherwise agreed).

It is possible that the Unitary Patent “package” will have to be re-negotiated between the remaining 25 participating member states, noting that UK was a big player in the initial negotiations as well as one of the three top-patenting countries in Europe and that with its withdrawal, the system will be less attractive for companies, especially in term of cost-effectiveness.

The UK could also possibly decide to ratify the UPC agreement to allow its set up, even if it were to leave the UP system eventually at a later date and this could be used as leverage during its negotiations with the EU. Yet, this situation would probably lead to some major issues to resolve regarding the effective application of the UPC system in the UK and in the EU, especially with the central division of the Unified Patent Court being created in London to hear chemical and pharmaceutical patent disputes, as provided by the UPC agreement.

The outcome of the Brexit therefore remains unclear, but it could certainly mean the end of or a significant delay in the launch of the Unitary Patent system, which was initially expected next year.

To read more about Stibbe's Brexit team and other newsletters about the Brexit consequences, please click here.

 

Team

Related news

02.09.2019 BE law
Stibbe verwelkomt Philippe Campolini als partner in praktijk intellectuele eigendom

Inside Stibbe - Brussel, 2 september 2019 – Stibbe is verheugd om Philippe Campolini als nieuwe vennoot in zijn Brussels kantoor te verwelkomen. Philippe is gespecialiseerd in het intellectueel eigendomsrecht en de life sciences sector. Zijn komst versterkt Stibbe’s toonaangevende IP-praktijk en beantwoordt aan nieuwe marktbehoeften in dit rechtsdomein. Philippe vervoegt Stibbe op 2 september 2019 en zal nauw samenwerken met IP-vennoot Ignace Vernimme.

Read more

02.09.2019 BE law
Philippe Campolini rejoint l’éminente pratique IP de Stibbe en qualité d’associé

Inside Stibbe - Bruxelles, 2 septembre 2019 – Le cabinet de Stibbe Bruxelles est ravi d’accueillir Philippe Campolini, avocat spécialisé en droit de la propriété intellectuelle et des sciences de la vie, en tant que nouvel associé. Son arrivée vient non seulement renforcer la pratique de référence du cabinet en la matière, mais également répondre à l’évolution des besoins du marché. Philippe rejoint le cabinet Stibbe le 2 septembre 2019. Il travaillera en étroite collaboration avec Ignace Vernimme, associé spécialisé en droit de la propriété intellectuelle.

Read more

02.09.2019 BE law
Philippe Campolini joins Stibbe’s leading IP practice as partner

Inside Stibbe - Brussels, 2 September 2019 – Stibbe is delighted to welcome IP lawyer and life sciences specialist Philippe Campolini as new partner in its Brussels office. Stibbe’s hiring of Philippe reinforces the firm’s leading intellectual property practice and responds to developing market needs. Philippe joins Stibbe on 2 September 2019 and will team up with IP law partner Ignace Vernimme.

Read more

21.03.2019 EU law
Ignace Vernimme, Floris ten Have and Manuel Campolini are speakers during the Legal Affairs Conference.

Speaking slot - Ignace Vernimme, IP Partner at Stibbe Brussels, moderates a roundtable discussion on 'second medical use patents'. Manuel Campolini, of-counsel at Stibbe Brussels, co-moderates this session. Floris ten Have, Competition and Regulation Partner at Stibbe Amsterdam, chairs a session on opportunities and challenges for biosimilar medicine developers.

Read more

Our website uses functional cookies for the functioning of the website and analytic cookies that enable us to generate aggregated visitor data. We also use other cookies, such as third party tracking cookies - please indicate whether you agree to the use of these other cookies:

Privacy – en cookieverklaring